Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.
Also called NCT07706075
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Muhammad Ali Javed
- Registry
-
NCT07706075
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07706075. Randomized; single masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2027-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
- Condition
- Atrial Fibrillation (AF)
- Condition
- Atrial Fibrillation With Rapid Ventricular Response
- Intervention (Drug)
- Verapamil Hydrochloride
- Intervention (Drug)
- Metoprolol tartrate
- Lead sponsor
- Muhammad Ali Javed
Record details
- Record id
cardio:ct-nct07706075- Content hash
158607125a4fa7e4cb55429b7d6798c779b16ca5e24de8f76dc1bfc07a72fd57